Popular on s4story
- The Shift Complex Launches with Refining Reality, a Book on Leadership and Complexity - 208
- Beyond Wealth and Recognition: Caribbean Author Lyndon Alexander Hall Redefines Success - 205
- Geospatial Innovation Comes to Sacramento: FOSS4G NA 2026 - 187
- New Historical Fiction Book Release - The Legend in the Stone by Cliff Ball - 168
- North Carolina Author Carrie Sybert Celebrates Three Published Books
- Freight Broker 911 CEO and President Milton Collier Is Rebuilding the Path Into Freight Brokerage
- New Children's Picture Book "Adam's Apple" Celebrates Childhood Curiosity and the Funny Misundersta
- Architects of Authoritarianism: The Claremont Institute and the Making of the MAGA New Right
- New Children's Picture Book "Tippy Tay" Explores the Dangers of Peer Pressure and the Importance of
- Sycamore Dove Releases "Loving Every Moment"
Similar on s4story
- Major FDA Victory; Preservative-Free Ketamine Approved Ahead of November 10 Goal Date as Commercial Launch Opportunity Comes Into Focus for NRx Pharma
- Longevity Academy Features Gail Humble, MD of KLOTHO SKIN in the Longevity Leaders Project
- Expanding Into Medically Supervised Wellness With Major Apollo Wellness Centers Announcement; Sibannac, Inc. (Stock Symbol: SNNC)
- Preston Dermatology & Skin Surgery Center and Dr. Sheel Desai Solomon Win Gold in Raleigh's Best Awards for Second Consecutive Year
- Mr Hospital Bed Cites Hill Rom Hospital Bed Models Best Value Home Care Hospital Beds 2026
- Hospital Direct Medical Equipment Company Seeing Growth in Used Refurbished Medical Equipment Sales
- Commercial Manufacturing Validation Completed as November 10 FDA Milestone Approaches; Critical FDA Milestone Close: NRx Pharmaceuticals NAS DAQ: NRXP
- Critical FDA Milestone much Closer as Preservative-Free Ketamine Review Advances: NRx Pharmaceuticals (N A S D A Q: NRXP)
- Acuvance Survey Finds ERP Integration Remains a Key Challenge as Healthcare Organizations Prepare for AI
- HSS Medical Supply Celebrates One-Year Anniversary of Its Top Performing Sales Team
Voltas Completes SAM.gov Registration, Opening In-House Medical Device Work to Federal Buyers
S For Story/10707060
Voltas of Cottage Grove, Minnesota, has an active SAM.gov registration (CAGE code 26GX5) as of October 27, 2026. Federal agencies and primes can now work with Voltas on medical device development, manufacturing and EtO sterilization in one facility.
COTTAGE GROVE, Minn. - s4story -- COTTAGE GROVE, Minn. Voltas has completed its registration in the federal System for Award Management (SAM.gov). The registration became active on October 27, 2026, and Voltas holds CAGE code 26GX5. Federal agencies, military research groups and prime contractors can now contract directly with Voltas for medical device development and manufacturing.
Voltas keeps engineering, regulatory work, manufacturing and sterilization in one facility at 8200 97th Street, Cottage Grove, MN 55016. A federal program can bring a patented idea, a research prototype or a napkin sketch, and work with one team through production.
The Voltas team handles R&D, weekly prototyping, mold flow analysis, die mold tooling, injection molding, balloon development, hydrophilic and hydrophobic coatings, cleanroom assembly, packaging and labeling, and distribution. Voltas has on-site two-pallet EtO sterilization capacity and runs sterilization validation in house. The facility is ISO 13485 compliant. The regulatory team supports Pre-Sub, 513(g) and 510(k) work.
More on S For Story
Government research programs often fund a device through early prototypes, then need a partner to take it to a build that can pass FDA review and scale. Voltas does both under one roof, so a program does not have to hand the design to a second company for tooling, assembly or sterilization.
Voltas has worked on 128 medical device projects and has 15 current clients. One project is sold in 10 countries.
Contracting officers and prime contractors can find Voltas on SAM.gov under CAGE code 26GX5, or reach the team at https://www.voltas.io.
About Voltas
Voltas is a medical device development and manufacturing company in Cottage Grove, Minnesota. Development Manufacturing. Everything. In House. Website: https://www.voltas.io. Phone: (651) 677-0675.
Media contact
Jason Scherer, CEO
jason.scherer@voltas.io
(651) 677-0675
https://www.voltas.io
Voltas keeps engineering, regulatory work, manufacturing and sterilization in one facility at 8200 97th Street, Cottage Grove, MN 55016. A federal program can bring a patented idea, a research prototype or a napkin sketch, and work with one team through production.
The Voltas team handles R&D, weekly prototyping, mold flow analysis, die mold tooling, injection molding, balloon development, hydrophilic and hydrophobic coatings, cleanroom assembly, packaging and labeling, and distribution. Voltas has on-site two-pallet EtO sterilization capacity and runs sterilization validation in house. The facility is ISO 13485 compliant. The regulatory team supports Pre-Sub, 513(g) and 510(k) work.
More on S For Story
- Premium Publishing USA Provides Full Publishing Support for First-Time
- Award-Winning Journalist Dianna Hobbs Releases 'Finding Gratitude in the Dark' on Her 50th Birthday
- TradeJARnal Launches Innovative Trading Journal to Help Stock and Options Traders Build Discipline and Smarter Trading Habits
- Pursant Founder Mark Herbick Joins STS Capital Partners as CEO
- Tampa Holiday Sessions: Captured by Mallary Opens 2026 Christmas Minis With Two New Sets
Government research programs often fund a device through early prototypes, then need a partner to take it to a build that can pass FDA review and scale. Voltas does both under one roof, so a program does not have to hand the design to a second company for tooling, assembly or sterilization.
Voltas has worked on 128 medical device projects and has 15 current clients. One project is sold in 10 countries.
Contracting officers and prime contractors can find Voltas on SAM.gov under CAGE code 26GX5, or reach the team at https://www.voltas.io.
About Voltas
Voltas is a medical device development and manufacturing company in Cottage Grove, Minnesota. Development Manufacturing. Everything. In House. Website: https://www.voltas.io. Phone: (651) 677-0675.
Media contact
Jason Scherer, CEO
jason.scherer@voltas.io
(651) 677-0675
https://www.voltas.io
Source: Voltas
0 Comments
Latest on S For Story
- Indies United is pleased to present our November 2026 book releases
- Poet Wardah Abbas Featured in Pyrrhic Press Publishing's Ink & Echo With "Hoomins and Other"
- Heart Attack Doesn't Slow Down Author Bruce Goldwell — 550 Books Published
- ALight Technology And Services Limited Advances Through Peachscore + Dealum Accelerator and Join LvlUp Labs
- International Misophonia Foundation Launches Sensory Accessible Technology Initiative to Address Overlooked Digital Accessibility Barriers
- Medusa: Before the Gorgon, Explore the Tragedy Behind the Monster
- Dr. Angelina Abong Atsimbom Introduces Three Books Connecting Workplace Well-Being, Relationships & Personal Resilience
- Italian Author Massimo Lorusso Shares a Journey of Faith, Family, and Resilience in The Vo
- RAS AP Consulting Advances 1099 Education and Readiness Initiative Through IFOL Training and Finance Technology Showcase
- Independent Publishing & Streaming Company Launches in Columbia, MO: Rebellion Entertainment Group
- Release Slated for Violet Wayne's 'The Nurse'
- Colorado Author Takes Young Readers on an Unforgettable Journey to Afghanistan
- New Book Announcement - The Ladder and the Gate by Rami Zeedan
- Heritage at Manalapan Announces New 3.875% First-Year Mortgage Rate Buydown (7.11 APR)
- Meet Cowboy Mike and Winston: The Little Pony with a BIG Mission to Change Children's Lives
- AthleteMerch.com Surpasses 100,000 Custom Items Delivered to Fans Nationwide
- Steve Weclew is Appointed by STS Capital Partners as Managing Director
- New Finnish Affiliate Site Ilmaiskierrokset.com Puts Wager-Free Spins in the Spotlight
- "From Rural Haiti to AI" Now Available on Amazon in English and French, With New Book Trailers
- Major FDA Victory; Preservative-Free Ketamine Approved Ahead of November 10 Goal Date as Commercial Launch Opportunity Comes Into Focus for NRx Pharma